Roberta A. Ballard is recognized for her contributions to neonatal medicine. In 1965, she graduated from the University of Chicago's medical school and has dedicated much of her life to research on newborn prenatal health.[1] Specifically, Dr. Ballard studies ways to treat and prevent chronic lung disease in premature infants. Some of her research includes the collection of data regarding how inhaled Nitric Oxide can help premature infants who are suffering from lung disease and are undergoing medical ventilation. [2] From her studies she was able to find that Nitric Oxide reduced the risk of death and shortened hospitalization time for infants born prematurely who suffer from lung disease. These contributions have helped to prevent chronic lung disease and brain injury harming infants. [3] Hospitals that Dr. Ballard is associated with include the Hospital of the University of Philadelphia, University of PA Medical Center/Presbyterian, Saint Christopher's Hospital for Children, and Children's Hospital of Philadelphia.[4] Dr. Ballard also served as a Professor of Pediatrics at the University of California, San Francisco School of Medicine.[5] Currently, she is Emeritus Professor of Pediatrics and Obstetrics and Gynecology at the University of Pennsylvania. While also being a professor, Dr. Ballard has contributed her knowledge in articles including the New England Journal of Medicine, Pediatrics, Journal of Perinatology, and more.[6] She has served on a number of scientific and medical boards including the American Board of Pediatrics in 1972 and is an author of the book Avery's Diseases of Newborns.[7] The book focuses on the care and treatment of neonates. Dr. Ballard's research and contributions have helped enhance technology and prevent infant death. Her improvements in technology have not only improved the lives of premature infants, but she also seeks to help women who are pregnant to assure they receive proper prenatal attention.